30
Participants
Start Date
February 7, 2018
Primary Completion Date
January 31, 2028
Study Completion Date
December 31, 2029
Pembrolizumab Injection [Keytruda]
200mg, IV, every three weeks, up to two years; After the first three doses, dosing can be changed to 400mg IV every 6 weeks, at the treating physician's discretion.
Metformin
500 mg, by mouth, twice a day for nine weeks.
RECRUITING
Univ of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Merck Sharp & Dohme LLC
INDUSTRY
Yana Najjar
OTHER